{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:41:14Z","timestamp":1778755274196,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.peptides.2009.09.005","type":"journal-article","created":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T09:48:00Z","timestamp":1252576080000},"page":"2309-2315","source":"Crossref","is-referenced-by-count":43,"title":["17\u03b2-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats"],"prefix":"10.1016","volume":"30","author":[{"given":"V.","family":"Shenoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Grobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Fraga-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Collamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Katovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2009.09.005_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13697130701361657","article-title":"IMS updated recommendations on postmenopausal hormone therapy","volume":"10","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.peptides.2009.09.005_bib2","doi-asserted-by":"crossref","first-page":"H1995","DOI":"10.1152\/ajpheart.01193.2007","article-title":"Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats","volume":"294","author":"Brosnihan","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1025438000942","article-title":"Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy","volume":"251","author":"Brower","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.peptides.2009.09.005_bib4","first-page":"S143","article-title":"Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system","volume":"11","author":"Brown","year":"1999","journal-title":"J Am Soc Nephrol Suppl"},{"key":"10.1016\/j.peptides.2009.09.005_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.HYP.38.3.692","article-title":"Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats","volume":"38","author":"David","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2009.09.005_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.HYP.0000256279.49882.d8","article-title":"Hypertensive cardiac remodeling in males and females. From the bench to the bedside","volume":"49","author":"Deschepper","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2009.09.005_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCRESAHA.108.190397","article-title":"Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation","volume":"104","author":"Donaldson","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.peptides.2009.09.005_bib8","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/01.HYP.30.5.1253","article-title":"Cardiac type-1 angiotensin II receptor status in deoxycorticosterone acetate-salt hypertension in rats","volume":"30","author":"Fareh","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2009.09.005_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.yjmcc.2004.11.013","article-title":"Estrogen receptor beta mediates gender differences in ischemia\/reperfusion injury","volume":"38","author":"Gabel","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.HYP.33.1.323","article-title":"Estrogen regulation of angiotensin-converting enzyme mRNA","volume":"33","author":"Gallagher","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2009.09.005_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/01.gme.0000222472.08593.e4","article-title":"Effect of estrogen and angiotensin-converting enzyme inhibitor on vascular remodeling in ovariectomized spontaneously hypertensive rats","volume":"13","author":"Garc\u00eda","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.peptides.2009.09.005_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1113\/expphysiol.2005.032060","article-title":"Effects of oestrogen treatment and angiotensin-converting enzyme inhibition on the microvasculature of ovariectomized spontaneously hypertensive rats","volume":"91","author":"Gim\u00e9nez","year":"2006","journal-title":"Exp Physiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0025-7125(03)00125-1","article-title":"Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system","volume":"88","author":"Gonz\u00e1lez","year":"2004","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.peptides.2009.09.005_bib14","doi-asserted-by":"crossref","first-page":"H2417","DOI":"10.1152\/ajpheart.01170.2005","article-title":"Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension","volume":"290","author":"Grobe","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib15","doi-asserted-by":"crossref","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","article-title":"Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)","volume":"292","author":"Grobe","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation","volume":"15","author":"Grodstein","year":"2006","journal-title":"J Womens Health"},{"key":"10.1016\/j.peptides.2009.09.005_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1196\/annals.1347.004","article-title":"Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence","volume":"1052","author":"Harman","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.peptides.2009.09.005_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement study follow-up (HERS II)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.peptides.2009.09.005_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.ATV.20.2.428","article-title":"In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy","volume":"20","author":"Higaki","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.peptides.2009.09.005_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.peptides.2009.09.005_bib21","doi-asserted-by":"crossref","first-page":"26F","DOI":"10.1016\/S0002-9149(01)02219-6","article-title":"Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence","volume":"90","author":"Hu","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp Physiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib23","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.92.9.2690","article-title":"Cardiac renin angiotensin system in the hypertrophied heart","volume":"92","author":"Iwai","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2009.09.005_bib24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1113\/expphysiol.2007.041392","article-title":"Role of ACE2 and Ang-(1-7) in 17 \u03b2-estradiol regulation of renal pathology in renal wrap hypertension","volume":"93","author":"Ji","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib25","first-page":"514","article-title":"Oral versus non-oral hormone replacement therapy: how important is the route of administration?","volume":"78","author":"John","year":"2007","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.peptides.2009.09.005_bib26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cca.2005.08.020","article-title":"Serum level of vascular endothelial growth factor is increased by estrogen replacement therapy in normotensive and DOCA\u2013salt hypertensive ovariectomized rats","volume":"365","author":"Khazaei","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.peptides.2009.09.005_bib27","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1006\/jmcc.1997.0476","article-title":"Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat","volume":"29","author":"Kolodgie","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1358\/mf.2003.25.7.778094","article-title":"Role of intracardiac renin-angiotensin-aldosterone system in extracellular matrix remodeling","volume":"25","author":"Lijnen","year":"2003","journal-title":"Methods Find Exp Clin Pharmacol."},{"key":"10.1016\/j.peptides.2009.09.005_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1385\/ENDO:24:3:217","article-title":"The rationale for low-dose hormonal therapy","volume":"24","author":"Lobo","year":"2004","journal-title":"Endocrine"},{"key":"10.1016\/j.peptides.2009.09.005_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.peptides.2009.09.005_bib31","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1112062","article-title":"Molecular and cellular basis of cardiovascular gender differences","volume":"308","author":"Mendelsohn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.peptides.2009.09.005_bib32","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.97.22.2197","article-title":"Estrogen modulates AT1 receptor gene expression in vitro and in vivo","volume":"97","author":"Nickenig","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2009.09.005_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/gme.0b013e31803167ab","article-title":"Estrogen and progestogen use in peri and postmenopausal women: March 2007 position statement of the North American Menopause Society","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.peptides.2009.09.005_bib34","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1503\/cmaj.051455","article-title":"A comprehensive view of sex-specific issues related to cardiovascular disease","volume":"176","author":"Pilote","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.peptides.2009.09.005_bib35","unstructured":"Rasband WS (1997\u20132005) ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, http:\/\/rsb.info.nih.gov\/ij\/."},{"key":"10.1016\/j.peptides.2009.09.005_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1027351808326","article-title":"Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy","volume":"17","author":"Remme","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.peptides.2009.09.005_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1677\/JOE-08-0199","article-title":"Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats","volume":"200","author":"Ricchiuti","year":"2009","journal-title":"J Endocrinol"},{"key":"10.1016\/j.peptides.2009.09.005_bib38","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.peptides.2009.09.005_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.CIR.95.1.39","article-title":"Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women","volume":"95","author":"Schunkert","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2009.09.005_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1258\/mi.2009.009018","article-title":"Hormone replacement therapy and cardiovascular disease revisited","volume":"15","author":"Stevenson","year":"2009","journal-title":"Menopause Int"},{"key":"10.1016\/j.peptides.2009.09.005_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yjmcc.2006.04.019","article-title":"17\u03b2-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts","volume":"41","author":"Stewart","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.peptides.2009.09.005_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2459\/JCM.0b013e328324991c","article-title":"Postmenopausal hormone therapy and the risk of cardiovascular disease","volume":"10","author":"Stramba-Badiale","year":"2009","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.peptides.2009.09.005_bib43","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/hc3601.095577","article-title":"17\u03b2-estradiol attenuates the development of pressure overload hypertrophy","volume":"104","author":"van Eickels","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2009.09.005_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.CIR.103.3.435","article-title":"Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats","volume":"103","author":"Wassmann","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2009.09.005_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.peptides.2009.09.005_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejphar.2009.05.016","article-title":"17\u03b2-estradiol inhibits angiotensin II-induced cardiac myofibroblast differentiation","volume":"616","author":"Wu","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2009.09.005_bib47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1113\/expphysiol.2008.042788","article-title":"Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction","volume":"93","author":"Zhan","year":"2008","journal-title":"Exp Physiol"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978109003635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978109003635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T08:21:22Z","timestamp":1545034882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978109003635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0196978109003635"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2009.09.005","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}